Schedule 13G ownership disclosure

Aura Biosciences Inc

Common Stock · CUSIP: 05153U107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • LONG FOCUS CAPITAL MANAGEMENT, LLC

    Shares: 3,319,582.00 · Class: 6.6%

  • JOHN HELMERS

    Shares: 3,319,582.00 · Class: 6.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001344676-25-000018
Form type
SCHEDULE 13G/A
Filer
Aura Biosciences, Inc.
CIK
CIK 1501796
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub